80
(82) Park SW, Lee CW, Kim HS, Lee NH, Young D, Hong MK, et al. Effects of cilostazol on angiographic
restenosis after coronary stent placement. American Journal of Cardiology 2000;86(5):499-503.
(83) FitzGerald DJ, Catella F, Roy L, FitzGerald GA. Marked platelet activation in vivo after intravenous
streptokinase in patients with acute myocardial infarction. Circulation 1988 Jan;77(1):142-50.
(84) Monnier L, Follea G, Mirouze J. Antithrombin III deficiency in diabetes mellitus: influence on vascular
degenerative complications. Horm Metab Res 1978 Nov;10(6):470-3.
(85) Takahashi H, Tsuda A, Tatewaki W, Wada K, Niwano H, Shibata A. Activation of blood coagulation and
fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and
plasmin-alpha 2-plasmin inhibitor complex. Thromb Res 1989 Sep 15;55(6):727-35.
(86) Collen D, Lijnen HR. Fibrin-specific fibrinolysis. Ann N Y Acad Sci 1992 Dec 4;667:259-71.
(87) Juhan-Vague I, Morange P, Christine AM. Fibrinolytic function and coronary risk. Curr Cardiol Rep
1999 Jul;1(2):119-24.
(88) Garg R, Kumbkarni Y, Aljada A, Mohanty P, Ghanim H, Hamouda W, et al. Troglitazone reduces
reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated
vasodilatation in obese subjects. Hypertension 2000 Sep;36(3):430-5.
(89) Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, et al. Suppression of nuclear factor-
kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and
a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 2001 Mar;86(3):1306-12.
(90) Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and
in vivo monitoring of ROS. Circulation 2003 Oct 21;108(16):1912-6.
(91) Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes,
and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004
May;24(5):816-23.
(92) Dandona P, Aljada A. Advances in diabetes for the millennium: diabetes and the endothelium.
MedGenMed 2004;6(3 Suppl):6.
(93) Szmitko PE, Wang CH, Weisel RD, de A, Jr., Anderson TJ, Verma S. New markers of inflammation and
endothelial cell activation: Part I. Circulation 2003 Oct 21;108(16):1917-23.
(94) Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P. Both lipid and protein intakes
stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and
mononuclear cells. Am J Clin Nutr 2002 Apr;75(4):767-72.
(95) Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P. Glucose intake induces an
increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue
factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix
metalloproteinase concentrations. Am J Clin Nutr 2004 Jul;80(1):51-7.
(96) Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, et al. Insulin inhibits intranuclear
nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an
anti-inflammatory effect? J Clin Endocrinol Metab 2001 Jul;86(7):3257-65.
(97) Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, et al. The suppressive effect of
dietary restriction and weight loss in the obese on the generation of reactive oxygen species by